Lung Therapeutics
Edit info- Founded: 2013
- Location: Austin, TX
- Employee range: 11 - 50
- Clinical stage: Clin2
- Therapy area: Loculated pleural effusion
- Drug types: LNG, GEN
- Lead product: LTI-01
- Funding: $36M C Jun 2019; $14M B Jul 2017
lungtx.com linkedin.com job board
Business:
Respiratory Treatments
Drug notes:
Also RD/Clin0 malignant pleural effusion; LTI-03 Clin1 idiopathic pulmonary fibrosis; LTI-05 RD/Clin0 cystic fibrosis; LTI-07 RD/Clin0 fibrotic conditions
About:
Lung Therapeutics is developing medicines for unmet medical needs in fibrosis and lung disease.
© 2025 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com